AVITA Medical, Inc. (RCEL) Financials

$5.47

$0.07 (-1.26%)
Last update: 04:00 PM EST
Day's range
$5.41
Day's range
$5.61
$100M$100M$50M$50M$0$0-$50M-$50M-$100M-$100MEarning20182018201920192020202020212021202220222023202320242024300%300%100%100%-100%-100%-300%-300%-500%-500%Profit Margin
Profit Margin
Revenue
Earnings

RCEL Income statement / Annual

Last year (2024), AVITA Medical, Inc.'s total revenue was $64.25 M, an increase of 28.14% from the previous year. In 2024, AVITA Medical, Inc.'s net income was -$61.85 M. See AVITA Medical, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 06/30/2021 06/30/2020 06/30/2019 06/30/2018 06/30/2017 06/30/2016
Operating Revenue $64.25 M $50.14 M $50.56 M $33.03 M $14.26 M $20.67 M $5.47 M $1.26 M $1.18 M $1.00 M
Cost of Revenue $9.09 M $7.78 M $8.87 M $6.10 M $2.97 M $4.31 M $1.27 M $737.70 K $505.64 K $401.57 K
Gross Profit $55.16 M $42.36 M $41.69 M $26.92 M $11.29 M $16.36 M $4.20 M $517.47 K $675.00 K $600.44 K
Gross Profit Ratio 0.86 0.84 0.82 0.82 0.79 0.79 0.77 0.41 0.57 0.6
Research and Development Expenses $20.36 M $20.82 M $20.35 M $15.67 M $8.46 M $13.28 M $8.00 M $8.45 M $6.27 M $3.46 M
General & Administrative Expenses $33.20 M $28.33 M $34.27 M $20.95 M $34.62 M $46.77 M $15.10 M $12.70 M $0.00 $6.51 M
Selling & Marketing Expenses $58.20 M $37.29 M $32.19 M $16.27 M $14.81 M $22.76 M $12.55 M $6.59 M $5.20 M $3.46 M
Selling, General & Administrative Expenses $91.39 M $65.63 M $66.46 M $37.92 M $49.43 M $70.61 M $27.65 M $21.21 M $13.90 M $10.93 M
Other Expenses $0.00 -$1.43 M $0.00 -$1.55 M $686.00 K $0.00 -$5.92 M $0.00 $0.00 $0.00
Operating Expenses $111.75 M $85.02 M $80.78 M $52.04 M $53.97 M $77.21 M $29.73 M $19.15 M $13.35 M $11.95 M
Cost And Expenses $120.84 M $92.80 M $89.65 M $58.14 M $56.94 M $81.51 M $31.00 M $19.88 M $13.85 M $12.36 M
Interest Income $0.00 $0.00 $23.50 K $0.00 $0.00 $47.82 K $0.00 $28.37 K $110.96 K $110.34 K
Interest Expense $5.36 M $1.14 M $0.00 $0.00 $33.00 K $0.00 $27.00 K $0.00 $0.00 $0.00
Depreciation & Amortization $1.13 M $632.00 K $1.46 M $673.00 K $465.00 K -$0.00 -$63.00 K $105.45 K $139.70 K $83.72 K
EBITDA -$55.34 M -$32.45 M -$39.57 M -$24.40 M -$41.53 M -$61.17 M -$25.26 M -$18.55 M -$12.53 M -$11.27 M
EBITDA Ratio -0.86 -0.65 -0.78 -0.74 -2.91 -2.96 -4.61 -14.78 -10.61 -11.25
Operating Income Ratio -0.88 -0.85 -0.8 -0.76 -2.99 -2.99 -4.66 -14.9 -10.73 -11.33
Total Other Income/Expenses Net -$5.20 M $7.34 M $1.29 M $18.00 K $686.00 K $946.20 K $305.00 K $43.24 K $110.96 K $110.34 K
Income Before Tax -$61.79 M -$35.32 M -$39.12 M -$25.10 M -$42.03 M -$60.90 M -$25.22 M -$18.66 M -$12.56 M -$11.24 M
Income Before Tax Ratio -0.96 -0.7 -0.77 -0.76 -2.95 -2.95 -4.61 -14.86 -10.64 -11.22
Income Tax Expense $54.00 K $66.00 K $52.88 K $42.00 K $4.00 K $5.80 K -$121.00 K $1.45 M $1.05 M $971.88 K
Net Income -$61.85 M -$35.38 M -$39.17 M -$25.14 M -$42.03 M -$60.90 M -$25.10 M -$17.21 M -$11.51 M -$10.27 M
Net Income Ratio -0.96 -0.71 -0.77 -0.76 -2.95 -2.95 -4.59 -13.71 -9.75 -10.25
EPS -2.39 -1.4 -1.57 -1.03 -2.07 -3 -2.78 -1.84 -1.72 -2.06
EPS Diluted -2.39 -1.4 -1.57 -1.03 -2.07 -3 -2.78 -1.85 -1.72 -2.06
Weighted Average Shares Out $25.88 M $25.33 M $25.00 M $24.36 M $20.29 M $20.29 M $253.33 M $9.30 M $6.69 M $4.99 M
Weighted Average Shares Out Diluted $25.88 M $25.33 M $25.00 M $24.36 M $20.29 M $20.29 M $253.33 M $9.33 M $6.70 M $4.99 M
Link